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ABSTRACT 
Background Parkinson’s disease (PD) affects driving ability. We aimed to determine the most 
critical impairments in specific road skills and in clinical characteristics leading to failure on a 
road test in PD. 
Methods In this cross-sectional study, certified driving assessment experts evaluated specific 
driving skills in 104 active, licensed drivers with PD using a standardized, on-road checklist and 
issued a global decision of pass/fail. Participants also completed an off-road evaluation assessing 
demographic features, disease characteristics, motor function, vision, and cognition. The most 
important driving skills and off-road predictors of the pass/fail outcome were identified using 
multivariate stepwise regression analyses. 
Results Eighty-six (65%) passed and 36 (35%) failed the on-road driving evaluation. Persons 
who failed performed worse on all on-road items. When adjusted for age and gender, poor 
performances on lateral positioning at low speed, speed adaptations at high speed, and left 
turning maneuvers yielded the best model that determined the pass/fail decision (R2 = 0.56). The 
fail group performed poorer on all motor, visual, and cognitive tests. Measures of visual 
scanning, motor severity, PD subtype, visual acuity, executive functions, and divided attention 
were independent predictors of pass/fail decisions in the multivariate model (R2 = 0.60). 
Conclusions Our study demonstrated that failure on a road test in PD is determined by 
impairments in specific driving skills and associated with deficits in motor, visual, executive, and 
visuospatial functions. These findings point to specific driving and off-road impairments that can 
be targeted in multimodal rehabilitation programs for drivers with PD.  
  
INTRODUCTION 
Driving a car requires intact motor, visual, and cognitive processes.(1) These functions can be 
compromised in Parkinson’s disease (PD), leading to a higher risk of failing an official road test. 
Between 28%(2) and 56%(3) of drivers with PD fail a fitness to drive evaluation compared to 
0%(4) to 12%(3) of age-matched drivers without PD.  
Drivers with PD exhibit difficulties with various on-road driving skills that require specific 
motor actions(4) (steering accuracy, lane positioning), trunk and head mobility(4, 5) (checking 
blind spot, back and side mirrors), attention(6) (driving under distraction), visual perception and 
scanning(7) (identification of traffic signs and landmarks), memory retrieval(8) (navigation), and 
rapid decision making at T junctions.(4, 9) Yet, it is unclear which specific driving impairments 
independently determine failure on road testing. The identification of these skills is essential to 
understand the mechanisms of unsafe driving and to develop a conceptual framework for driving 
rehabilitation in PD. 
In an evidence-based review, motor scores of the Unified Parkinson’s Disease Rating Scale 
(UPDRS III), functional reach, contrast sensitivity, Trail Making Test B, Useful Field of View 
(UFOV), and Rey-Osterrieth Complex Figure (ROCF) showed to be predictive of on-road 
performance in PD.(10) These findings indicate that impaired on-road driving ability in PD may 
be ascribed to a complex interplay of motor and non-motor symptoms. However, the 
independent effect of different off-road deficits on specific driving impairments and failure on 
road testing is yet to be established.(10) 
The aims of this study were (1) to determine the specific on-road items that lead to failure on a 
road test and (2) to identify the underlying motor, visual, and cognitive skills that predict poor 
performance on critical driving abilities and overall failure on road testing in PD.  
 
METHODS 
Participants. Persons with PD were recruited from 2006 to 2012 through the Movement 
Disorders Clinic of the University Hospitals Leuven and the Center for Evaluation of Fitness to 
drive (CARA) of the Belgian Road Safety Institute. Participants recruited from the Clinic 
constituted a consecutive sample without apparent driving problems, whereas subjects recruited 
from CARA were referred for an on-road evaluation because of concerns with driving. The 
expert panel at CARA rendered a multidisciplinary decision on participants’ fitness to drive 
based on road test performance and off-road abilities (e.g., motor, visual, cognitive testing).(2, 
11) In this study, we used the unpublished data of the CARA evaluation to investigate the 
mechanisms underlying failure on the road test.  
Inclusion criteria were (I) valid driver’s license before diagnosis, (II) driving at least 300 km in 
the previous year, (III) Hoehn and Yahr (H&Y) ‘on’ stage 1 – 3, (IV) a maximum score of 1 on 
the Clinical Dementia Rating (CDR) scale(12) in accordance with the guidelines on driving and 
dementia,(13) and (V) minimum binocular acuity of 20/40 as stipulated by Belgian law. 
Participants were excluded if they had (I) deep brain stimulation, (II) unpredictable motor 
fluctuations, and (III) any comorbidity hindering driving. 
Out of 123 persons who met the eligibility criteria, 14 declined participation, three withdrew 
consent, and two dropped out before testing due to medical reasons. Thus, 104 persons (63 from 
the Clinic and 41 from CARA) took part in the study. Testing started approximately 30 to 45 
minutes after medication intake to minimize the effect of predictable wearing-off on test results 
and occurred in random sequence at two different locations on two separate days. Demographic 
variables, disease characteristics, and driving history were collected at the University Hospitals 
Leuven. The off-road battery and on-road test at CARA took 3 to 4 hours to complete. The 
median (Q1 – Q3) time interval between assessments was 17 (4 – 32) days. The study was 
approved by the local ethics committee. All participants signed the informed consent form. 
 
Demographic, driving, and disease characteristics. Demographic characteristics such as 
gender, age, and years of education were documented. Participant’s self-appraisal of driving 
fitness, driving experience, driving exposure, and number of traffic tickets and crashes in the 5 
years prior to testing composed the driving survey. Disease characteristics included disease 
duration, H&Y ‘on’ score, Epworth Sleepiness Scale,(14) CDR,(12) and UPDRS II (activities of 
the daily living).(15) PD medication intake was collected including levodopa-equivalent daily 
dosage (LED),(16) and use of amantadine, MAO-B inhibitors and anticholinergic medication.  
 
The road test at CARA. The standardized 20-km road test started in a residential area in the 
vicinity of Brussels, proceeded to a 2-way, 4-lane highway section, continued to an urban 
section, and terminated at the evaluation center. All road tests were carried out in an Opel Astra, 
equipped with dual controls to ensure standardization and safety, by a team of four occupational 
or physical therapists certified to conduct driving evaluations. The assessor communicated with 
the participants at regular time intervals to evaluate the effect of distraction on driving ability. 
The on-road assessor was blind to participants’ results on the neuropsychological test battery. 
The Test Ride for Investigating Practical fitness to drive (TRIP) checklist was used to record 
participants’ driving performance immediately after completion of the road test. The TRIP has 
established reliability and validity,(17) and has been used to determine driving deficits in 
neurodegenerative disorders.(2, 11, 18) The TRIP consisted of 13 items of driving ability: lateral 
position on the road at speed (I) below and (II) above 50 km/h; (III) mechanical operations; 
speed adaptations at speed (IV) below and (V) above 50 km/h; gap distance at speed (VI) below 
and (VII) above 50 km/h; (VIII) lane position change; (IX) anticipation and perception of road 
signs and traffic signals; (X) visual behavior and communication; (XI) understanding, insight, 
and quality of traffic participation; (XII) turning left; and (XIII) merging into traffic stream. The 
49 subitems of the TRIP were each scored on a 4 point ordinal scale, giving a total score range 
from 49 – 196. The items were categorized into 4 clusters(19) that closely resembled the 
hierarchic levels of driving skill.(20) The operational cluster (items I – III) was time-dependent 
(milliseconds) and relied on automatic, motor processes.(19, 20) The tactical cluster (items IV – 
VIII) reflected driving actions that needed to be executed within seconds and involved executive 
functions including attention, flexibility, judgment, and adaptation strategies.(19, 20) The visuo-
integrative cluster (items IX – XI) involved visuospatial, visuoperceptual and higher-order 
cognitive skills.(19) The mixed cluster (items XII – XIII) consisted of items that integrated all 
abovementioned maneuvers.(19) 
The pass/fail decision on the road test was the main dependent variable. Participants allocated to 
the pass category showed no functional deficits that interfered with on-road driving or adequate 
compensational strategies. Those assigned to the fail category showed poor overall performance 
on the TRIP evaluation or incurred serious adverse events that necessitated physical intervention 
of the on-road examiner (e.g., emergency brake, taking over the steering wheel).  
Off-road testing battery at CARA. A detailed description of the visual and neuropsychological 
tests can be found in the supplementary material (e-methods).  
Visual sensory information was gathered using the binocular acuity,(21) kinetic vision,(21) and 
Pelli-Robson contrast sensitivity tests.(22) 
Motor symptoms were assessed using UPDRS III ‘on’.(15) Participants were classified in terms 
of motor subtype as Postural Instability and Gait Disorder (PIGD), Tremor dominant (TD) or 
Indeterminate (IND) based on the relative predominance of tremor and gait/fall scores of the 
UPDRS II and UPDRS III, according to established clinical criteria.(23)  
The cognitive battery was administered by board-certified neuropsychologists, who were blind to 
participants’ results on the road test.  
Executive functions and attention were evaluated using the 4-choice reaction time,(24) executive 
control,(25) incompatibility,(25) UFOV™,(26) and divided attention tests.(25) 
Visuospatial functions were assessed using the ROCF(27) and visual scanning tests.(25)  
 
Statistical analysis. Variables were screened for normality using the Kolmogorov-Smirnov test. 
All interval/ratio variables were not normally distributed. Chi-square, Fisher’s Exact and 
Wilcoxon rank rum tests were used to explore differences between groups. Variables with p < 
0.10 were subjected to multivariate stepwise logistic regression analysis. We used a forward 
selection procedure with a liberal entry criterion (p < 0.15) since p values < 0.05 may fail to 
identify important associations between variables.(28) The retain criterion remained stringent at 
p < 0.05. We verified for collinearity between independent variables by calculating variance 
inflation factors (VIF). The square root of VIF indicates how much of the standard error of the 
estimate is increased due to collinearity compared with a situation where the covariates are 
uncorrelated. A VIF score of 10 or higher was considered to indicate substantial collinearity.(29) 
Spearman rank correlations (ρ) were calculated between off-road and on-road items. All 
statistical analyses were performed with SAS Enterprise 4.3 software. Two-tailed P values < 
0.05 were considered significant. 
 
RESULTS 
All 104 participants had mild to moderate disease severity (Table 1). Nineteen were in H&Y 
stage 1, 41 in stage 2, and 44 in stage 3. The CARA referral group only scored worse on UPDRS 
III (p = 0.02). Eighteen participants (29%) recruited from the Clinic and another 18 (44%) 
recruited from CARA failed the road test (X2 = 2.58, p = 0.11). 
 
In all, 36 (35%) out of the 104 participants failed the road test (Table 2). Participants who failed 
were significantly older (p < 0.001), had longer driving history (p = 0.008), and drove less 
kilometers/year (p = 0.007) than those who passed. They were also more severely disabled as 
indicated by longer disease history (p = 0.03) and higher H&Y (p = 0.0007), CDR (p < 0.0001), 
and UPDRS II (p = 0.0002) scores. No differences were found in PD medication intake between 
the pass/fail groups.  
Without exception, the fail group performed worse on all motor, visual sensory, executive and 
attention, and visuospatial tests (Table 2).The proportion of participants failing the on-road 
assessment was higher in the PIGD group compared to the TD group (46% vs 7%, post-hoc 
Fisher’s Exact, p < 0.0001). The on-road failure rate of the IND group (33%) did not 
significantly differ from the other two groups.  
The fail group scored worse on all driving items (Table 3) compared to the pass group (p < 
0.0001). 
 
All on-road items were entered in the multivariate logistic regression. Age and gender were 
forced into the model. Lateral position on the road at speed below 50 km/h, speed adaptations at 
speed above 50 km/h, and turning left showed to be most predictive of the on-road pass/fail 
decisions (R2 = 0.56; Table 4). The VIF scores ranged between 2.13 and 2.91, indicating no 
substantial collinearity between predictors. 
 
Moderate correlations were found between the off-road and on-road items. Lateral position on 
the road at speed below 50 km/h were associated with movement time of the 4-choice reaction 
time test (ρ = -0.46, p < 0.0001), UPDRS III (ρ = -0.42, p < 0.0001), and visual scanning (ρ = -
0.40, p < 0.0001). CDR score (ρ = -0.45, p < 0.0001), UFOV total score (ρ=-0.44, p < 0.0001), 
and visual scanning (ρ = -0.44, p < 0.0001) correlated with speed adaptations at speed above 50 
km/h. UFOV selective (ρ = -0.46, p < 0.0001), executive control (ρ = -0.43, p < 0.0001), and 
visual scanning (ρ = -0.43, p < 0.0001) correlated with left turning maneuvers. 
All univariate variables with p < 0.10 (Table 2) were entered in the multivariate regression to 
predict the pass/fail decision. After adjustment for age and gender, visual scanning, UPDRS III 
scores, motor subtype, binocular visual acuity, incompatibility, and UFOV divided attention 
yielded the best model to determine outcome on the road test (R2 = 0.60; Table 5). The odds of 
failing the road test was 24 times higher in the PIGD group than in the TD group. The VIF scores 
of the variables were low (range 1.09 – 2.40). 
DISCUSSION 
The novel contribution of our study to the field of driving in PD is the identification of critical 
impairments in specific driving skills that lead to failure on road testing: lateral position on the 
road at low speed, speed adaptations at high speed, and left turn maneuvers. Furthermore, we 
identified the underlying motor, visual, and cognitive impairments that predict failing the road 
test and performing poorly on these critical road skill items.  
 
The critical impairments in road skills can be mapped onto existing theoretical frameworks on 
driving.(20) Lateral vehicle control at low speed is the most basic operational skill that is 
required for safe driving.(30) Several on-road(4) and driving simulator(31) experiments have 
found that drivers with PD exhibit problems keeping their car steady on the road. Vehicle control 
showed to correlate with motor functions (UPDRS III, motor reaction time) as expected since it 
involves basic operational skills.(20) Speed adaptation at higher speed is a tactical driving skill 
that requires drivers to constantly change their speed according to the posted speed limits, the 
speed of other cars, and the traffic density. In line with current knowledge,(32) impairments in 
speed adaptation showed to be associated with reduced cognitive abilities, especially in 
executive functions and attention. Turning left is considered among the most complex driving 
skills and the main cause for car crashes in older drivers.(33) The complexity of this driving skill 
is reflected by its association with higher order cognitive skills including visual scanning, 
working memory, cognitive inhibition, and selective attention.  
 
On-road performance is determined by multidimensional factors involving both motor and non-
motor aspects of PD. Independently of age and gender, (1) motor subtype, (2) motor symptom 
severity, (3) binocular acuity, (4) executive dysfunction (incompatibility), (5) divided attention, 
and (6) visual scanning provided the best predictive model of on-road failure in PD. The model 
explained 60% of the variance which is consistent with other studies.(34) 
Previous studies demonstrated a relationship between impaired driving ability (on-road tests and 
car crashes) and motor components of PIGD (e.g., postural instability, functional reach or rapid 
pace walking).(3, 5, 35) The PIGD subtype is also associated with worse non-motor symptoms, 
including visual sensory, executive, and visuospatial dysfunction, which compromise 
instrumental daily-life activities.(36) Our results suggest that PIGD subtype is predictive of on-
road driving performance, above and beyond motor severity scores.  
Although UPDRS III ‘off’ scores proved to be better predictors of road testing,(10) we preferred 
to assess motor symptom severity in the ‘on’ medication phase because this status most likely 
reflects the condition in which persons are driving. Most studies reported primarily cognitive and 
visual predictors for road performance,(3, 5-8) mainly using dual task paradigms.(5-8) In the 
same cohorts,(5-8) motor dysfunction was an independent predictor of simulated driving when 
hazardous events were present that required fast reaction times.(8) In the present study, on-road 
tests were administered in a naturalistic traffic environment where potentially hazardous 
situations were constantly present, which may explain why motor impairment is associated with 
on-road performance.  
Basic visual sensory dysfunction is often seen in mild to moderate PD.(37) In a cohort of 84 
drivers with PD, significant associations were found between reduced far visual acuity and 
number of at-fault safety errors on the road.(35) Our results confirm the associations between 
visual acuity and impaired driving, independent of age-related ocular pathologies.  
We also observed differences in executive and attention between pass and fail groups, consistent 
with the findings of a recent evidence-based review.(10) Executive dysfunction is probably the 
most reported cognitive deficit in PD as part of global mild cognitive impairment, even in the 
early phases of the disease.(38) Executive dysfunction in PD encompasses deficits in planning 
and problem solving, decision making, set shifting, cognitive flexibility and interference, 
working memory, and selective attention,(38) all critical abilities for driving. 
Finally, visual scanning emerged as the most important predictor of on-road failure and was 
significantly associated with the three most predictive on-road skill items. This finding is in 
agreement with a study that reported deteriorated visual scanning while driving in PD.(7) Visual 
scanning assesses the capability of actively exploring the visual field and is mediated by visual 
sensory and visual processing functions in addition to intact head and ocular movements in order 
to shift gaze, scan, and localize the target of interest among a clutter of distracters.(39) 
 
A secondary but interesting finding study was lack of difference in pass/fail rates between 
participants referred for official driving evaluation at CARA (due to concerns raised by 
themselves, their family physicians, proxy, insurance company, or prosecution office)(11) and 
consecutive participants recruited from the Clinic who had no reported driving problems. The 
CARA referral group only showed worse UPDRS III scores. These findings suggest that the risk 
of poor road performance might go unrecognized in patients with lesser motor symptom severity 
from the community-dwelling PD population.  
We used stringent eligibility criteria to mitigate the effect of age-related conditions on driving 
safety. Also, more than half of the patients were volunteers with no apparent driving problems 
before testing. This selection and participation bias may have led to an overrepresentation of safe 
drivers and may limit generalization of the findings to the population of PD drivers. Second, we 
could not determine a specific cut-off value for failing the on-road test, implicating that there is 
some subjectivity involved in failing drivers with PD. We made sure participants were tested 
when they felt optimal and we blinded the road assessor for the clinical and neuropsychological 
tests. Still, other factors (fatigue, personality characteristics, familiarity with the vehicle and road 
course) that were not measured may have contributed to the pass/fail decision. Finally, we chose 
to classify the motor subtypes of PD according to the most commonly used method of Jankovic 
et al.(23) This classification is easy to use in clinical practice, however, it is not confirmed by 
data-driven approaches.  
 
Training programs for persons with mild to moderate PD may be useful to improve driving skills 
and prolong the preservation of mobility. Pilot studies on the efficacy of driving rehabilitation 
programs show that there is potential to improve driving skills in PD.(40) Our results provide a 
potential framework for future driving rehabilitation programs. For example, contextual training 
on the road or in a driving simulator in PD may focus on vehicle control, speed adaptations, and 
left turn maneuvers, whereas non-contextual rehabilitation may include physical therapy to 
address motor deficits, cognitive training to address visuospatial impairments, executive 
dysfunction and attention (e.g., speed of processing training), and compensation strategies to 
improve visual acuity (e.g., corrective lenses). 
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Table 1 Characteristics of the total PD group and two recruitment groups  
Variables All (n = 104) Clinic (n = 63) CARA (n = 41) p value 
Demographics n (%) n (%) n (%) χ2  
  Gender, male 87 (84) 54 (86) 33 (80) 0.48 
 median (Q1 – Q3) median (Q1 – Q3) median (Q1 – Q3) Wilcoxon 
  Age, y 66 (59 – 73) 66 (60 – 73) 64 (53 – 73) 0.54 
  Education, y 13 (11 – 16) 13 (11 – 15) 13 (11 – 16) 0.80 
Driving variables n (%) n (%) n (%) Fisher 
  Self-appraisal of driving fitness 
(NR/R/U) 76 (73)/28 (27)/0 (0) 48 (76)/15 (24)/0 (0) 28 (68)/13 (30)/0 (0) 0.37 
 median (Q1 – Q3) median (Q1 – Q3) median (Q1 – Q3) Wilcoxon 
  Driving history, y 42 (36 – 49) 42 (38 – 50) 41 (33 – 48) 0.27 
  Driving exposure, 10³ km 10 (5 – 15) 10 (5 – 15) 10 (5 – 12.50) 0.76 
  Traffic tickets in last five years, n 0 (0 – 1) 0 (0 – 1) 0 (0 – 1) 0.35 
  Crashes in last five years, n 0 (0 – 0) 0 (0 – 0) 0 (0 – 1) 0.06 
Disease characteristics median (Q1 – Q3) median (Q1 – Q3) median (Q1 – Q3) Wilcoxon 
  Disease duration, y 6 (4 – 9) 6 (3 – 10) 6 (4 – 7) 0.82 
  Hoehn and Yahr ‘on’, /5 (↓) 2 (2 – 3) 2 (2 – 3) 2 (2 – 3) 0.29 
  Epworth Sleepiness Scale,a /27 (↓) 5 (3 – 8) 5 (4 – 9) 5 (3 – 6.5) 0.32 
  Clinical Dementia Rating,a /3 (↓) 0 (0 – 0.25) 0 (0 – 0.5) 0 (0 – 0) 0.56 
  UPDRS II,a /48 (↓) 9 (5 – 12.50) 9 (4 – 12) 11 (7 – 13) 0.15 
  UPDRS III,a /108 (↓) 23 (16 – 33) 21 (16 – 29) 28 (18 – 37) 0.02  
  L-dopa equivalent dosage, mg/day 463 (275 – 668) 450 (255 – 610) 490 (300 – 775) 0.51 
 n (%) n (%) n (%) Fisher 
  Use of amantadine, yes 10 (10) 7 (11) 3 (7) 0.73 
  Use of anticholinergics, yes 8 (8) 6 (9) 2 (5) 0.47 
 n (%) n (%) n (%) χ2 
  Use of MAO-B inhibitors, yes 36 (35) 18 (29) 18(44) 0.11 
  Motor subtype (PIGD/TD/IND)a 59 (59) / 29 (29) /12 (12) 33 (52) / 23 (37) / 7 (11) 26 (70) / 6 (16) / 5 (14) 0.73 
a Missing data of four persons.   
Abbreviations: CARA = Center for Evaluation of Fitness to Drive and Car Adaptations; IND, Indeterminate; NR = No Restrictions on 
driver’s license needed; PIGD, Postural Instability and Gait Disorder; PD = Parkinson’s disease; R = Restrictions on driver’s license 
needed; ROCF = Rey-Osterrieth Complex Figure; TD = Tremor Dominant; U = subject considers himself Unfit to drive; UFOV, 
Useful Field Of View; UPDRS II, Unified Parkinson’s Disease Rating Scale Activities of the Daily Living; UPDRS III Unified 
Parkinson’s Disease Rating Scale motor section. 
Upward arrows indicate better performance with higher scores; downward arrows indicate worse performance with higher scores. 
 
 Table 2 Differences in demographics, disease characteristics and off-road performance between pass and fail groups 
Off-road variables Pass (n = 68) Fail (n = 36) p value 
Demographic and disease characteristics n (%) n (%) χ2  
  Gender, male 57 (84) 30 (83) 0.95 
 median (Q1 – Q3) median (Q1 – Q3) Wilcoxon 
  Age, y 63 (53 – 69) 72 (65 – 75) < 0.0001 
  Education, y 14 (11 – 16) 12 (11 – 15) 0.39 
  Driving history, y 41 (32 – 48) 46 (41 – 53) 0.008 
  Annual mileage, 10³ km 10 (7 – 19) 8 (5 – 10) 0.007 
  Traffic tickets in last five years, n 0 (0 – 1) 0 (0 – 0) 0.14 
  Crashes in last five years, n 0 (0 – 0) 0 (0 – 1) 0.12 
  Disease duration, y 5 (3 – 9) 6 (5 – 10) 0.03 
  Hoehn and Yahr ‘on’, /5 (↓) 2 (2 – 3) 3 (2 – 3) 0.0007 
  Epworth Sleepiness Scale,a /27 (↓) 5 (4 – 8) 5 (3 – 8) 0.84 
  Clinical Dementia Rating,a /3 (↓) 0 (0 – 0) 0.50 (0 – 0.50) < 0.0001 
  UPDRS II,a /48 (↓) 7 (4 – 11) 12 (8 – 14) 0.0002 
  L-dopa equivalent dosage, mg/day 463 (290 – 763) 433 (268 – 600) 0.54 
 n (%) n (%) Fisher 
  Use of amantadine, yes 6 (9) 4 (11) 0.74 
  Use of anticholinergics, yes 6 (9) 2 (6) 0.71 
 n (%) n (%) χ2 
  Use of MAO-B inhibitors, yes 24 (35) 12 (33) 0.84 
Motor tests n (%) n (%) Fisher 
  Motor subtype (PIGD/TD/IND)a 32 (54) / 27 (93) / 8 (67) 27 (46) / 2 (7) / 4 (33) 0.001 
 median (Q1 – Q3) median (Q1 – Q3) Wilcoxon 
  UPDRS III,a /108 (↓) 20 (13 – 25) 35 (26 – 43) < 0.0001 
  4-choice motor reaction time,a ms (↓) 274 (226 – 338) 390 (304 – 427) < 0.0001 
Visual tests    
  Binocular visual acuity, /10 (↑) 10 (8 – 10) 8 (8 – 8) < 0.0001 
  Kinetic vision,a /9 (↑) 7 (6 – 8) 6 (5 – 7) 0.004 
  Contrast sensitivity, /2.25 (↑) 1.80 (1.65 – 1.95) 1.65 (1.50 – 1.65) < 0.0001 
Executive function and attention tests     
  4-choice decision time,a ms (↓) 377.50 (345 – 425) 416 (383 – 467) 0.001 
  Executive control, omissions (↓) 1 (0 – 2) 4.50 (2 – 8) < 0.0001 
  Incompatibility, errors (↓) 1 (1 – 2) 2.50 (0 – 7) 0.04 
  UFOV total score, % (↓) 7.50 (0 – 12.50) 27.50 (7.50 – 40) < 0.0001 
  UFOV speed of processing, % (↓) 0 (0 – 0) 0 (0 – 0) 0.01 
  UFOV divided attention, % (↓) 0 (0 – 0) 5 (0 – 11.50) < 0.0001 
  UFOV selective attention, % (↓) 7.50 (0 – 12.50) 17.50 (7.50 – 25) 0.0007 
  Divided attention, omissions (↓) 1.50 (0 – 3) 3.50 (1 – 5) 0.0006 
Visuospatial tests    
  ROCF, /36 (↑) 35.50 (34 – 36) 34 (31 – 35) 0.0003 
  Visual scanning, ms (↓) 3343 (2795 – 4105) 5001 (4027 – 5736) < 0.0001 
a Missing data of four persons. 
Abbreviations: IND, Indeterminate; PIGD, Postural Instability and Gait Disorder; ROCF = Rey-Osterrieth Complex Figure; 
TD = Tremor Dominant; UFOV, Useful Field Of View; UPDRS II, Unified Parkinson’s Disease Rating Scale Activities of 
the Daily Living; UPDRS III Unified Parkinson’s Disease Rating Scale motor section. 
Upward arrows (↑), better performance with higher scores; downward arrows (↓), worse performance with higher scores. 
Table 3 On-road driving performance in the pass and fail groups 
Item Variable Score 
range 
Pass (n = 68) 
median (Q1 – Q3) 
Fail (n = 36) 
median (Q1 – Q3) 
p value 
Wilcoxon 
 Total TRIP score 49 – 196  196 (185 – 196) 146 (123 – 167)  < 0.0001 
 Operational cluster     
I Lateral position on the road at speed below 50 
km/h 
2 – 8  8 (8 – 8) 6 (6 – 8) < 0.0001 
II Lateral position on the road at speed above 50 
km/h 
2 – 8 8 (8 – 8) 6 (4 – 8)  < 0.0001 
III Mechanical operations 3 – 12  12 (12 – 12) 11 (9 – 12) < 0.0001 
 Tactical cluster     
IV Speed adaptations at speed below 50 km/h 2 – 8 8 (8 – 8) 6 (6 – 8) < 0.0001 
V Speed adaptations at speed above 50 km/h 2 – 8 8 (8 – 8)  5 (4 – 6) < 0.0001 
VI Gap distance at speed below 50 km/h 2 – 8 8 (8 – 8) 8 (6 – 8) < 0.0001 
VII Gap distance at speed above 50 km/h 2 – 8 8 (8 – 8) 6 (4 – 8) < 0.0001 
VIII Lane position change 5 – 20  20 (20 – 20)  16 (14 – 20) < 0.0001 
 Visuo-integrative cluster     
IX Anticipation and perception of signs and traffic 
lights  
4 – 16  16 (16 – 16)  11 (8 – 16)  < 0.0001 
X Visual behavior and communication 8 – 32  32 (28 – 32) 23 (16 – 25)  < 0.0001 
 Mixed cluster     
XI Understanding, insight and quality of traffic 
participation 
2 – 8 8 (8 – 8) 6 (4 – 6) < 0.0001 
XII Turning left 9 – 36  36 (34 – 36) 26 (23 – 29)  < 0.0001 
XIII Joining the traffic stream 6 – 24  24 (24 – 24)  18 (15 – 22) < 0.0001 
Abbreviations: TRIP, Test Ride for Investigating Practical fitness to drive; Wilcoxon, Wilcoxon rank sum test 
 
  
Table 4 Multivariate logistic regression of the road items to determine on-road driving decisions 
Variable Unit increase Odds Ratio 95% Confidence Interval P value 
   Lower CI Higher CI  
Agea  1 year 1.211 1.033 1.419 0.02 
Gendera m vs f 0.146 0.009 2.427 0.18 
Lateral positioning on the road at speed below 50 km/h  1 point 0.235 0.082 0.675 0.007 
Speed adaptations at speed above 50 km/h 1 point 0.257 0.100 0.659 0.005 
Turning left 1 point 0.762 0.608 0.955 0.02 
a Age and gender were forced in the model.  
Abbreviations: CI, Confidence Interval 
 
  
Table 5 Multivariate logistic regression of the off-road battery to determine on-road decisions 
Variable Unit increase Odds Ratio 95% CI p value 
Agea 1 year 1.168 1.034 1.320 0.01 
Gender a m vs f 0.390 0.028 5.397 0.48 
Visual scanning 1 millisecond 1.003 1.001 1.005 0.002 
UPDRS III ‘ON’ 1 point 1.168 1.053 1.296 0.003 
Motor subtype      
 TD vs IND 0.113 0.001 8.601 0.32 
 PIGD vs IND 1.256 0.889 1.364 0.68 
 PIGD vs TD 24.483 2.334 54.895 0.0009 
Binocular acuity 1 point 0.319 0.133 0.764 0.01 
UFOV divided attention 2.5% 0.758 0.582 0.987 0.04 
Incompatibility 1 error 0.841 0.714 0.991 0.04 
a Age and gender were forced in the model. 
Abbreviations: CI, Confidence Interval; UPDRS III, Unified Parkinson’s Disease Rating Scale motor 
section; UFOV, Useful Field Of View; TD, tremor-dominant; IND, indeterminate; PIGD, Postural 
Imbalance and Gait Disorder. 
 
 
 
